Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Dan P, Zandberg"'
Autor:
Dan P. Zandberg, Chang-Sook Hong, Andrew Swartz, Ronan Hsieh, Jennifer Anderson, Robert L. Ferris, Brenda Diergaarde, Theresa L. Whiteside
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-9 (2024)
Abstract Background Biomarkers that effectively predict response to anti-PD-1 mAb therapy in cancer patients are an unmet need. We evaluated the utility of small extracellular vesicles (sEV) as biomarkers of response to immunotherapy in recurrent/met
Externí odkaz:
https://doaj.org/article/3dff2e9e2cdf4546b2911d511fe565fd
Autor:
Robert L Ferris, Tullia C Bruno, Dan P Zandberg, Lisa A McIlvried, Andre A Martel Matos, Marci L Nilsen, Sebastien Talbot, David N Taggart, Lorin K Johnson, Nicole N Scheff, Mona M Yuan, Megan A Atherton, Fendi Obuekwe, Amin Reza Nikpoor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Immune checkpoint inhibitors (ICIs) are becoming the standard of care for recurrent and metastatic cancer. Opioids, the primary treatment for cancer-related pain, are immunosuppressive raising concerns about their potential to interfere wi
Externí odkaz:
https://doaj.org/article/62c796305d4944379fd6f5c90f15eae9
Autor:
Kriti Shah, David A. Geller, Samer Tohme, Michael Antoni, Cramer J. Kallem, Yoram Vodovotz, Rekha Ramanathan, Raam Naveen, MacKenzie Geroni, LaNita Devine, Aarshati Amin, Gauri J. Kiefer, Dan P. Zandberg, Vincent Reyes, Jennifer L. Steel
Publikováno v:
Current Oncology, Vol 30, Iss 10, Pp 8826-8840 (2023)
Objectives: The aims of the study were to (1) describe types of pain in cancer patients, (2) examine the predictors and consequences of pain, (3) investigate the association between type of pain and survival, and (4) examine potential biological medi
Externí odkaz:
https://doaj.org/article/76ca57ffd33a46a9b416d166661d8ac8
Autor:
Christine H Chung, Lara A Dunn, Ibrahima Soumaoro, Leonardo Nicacio, Dan P Zandberg, Douglas Adkins, Tanguy Y Seiwert, Nabil F Saba, Lova Sun, Thomas J George, William N William, Kristi Schmidt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/17b76e75d5a34466a55abfaee12a9987
Autor:
Lazar Vujanovic, Riyue Bao, Uma Duvvuri, Seungwon Kim, Robert Ferris, Aditi Kulkarni, Patricia Santos, Dan P Zandberg, Simon Chiosea, Housaiyin Li, Brian Isett, Joy Marion, Mark Kubik
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/eff971b9b63e47ca9db680664823406f
Autor:
Steven Borson, Yongli Shuai, Barton F. Branstetter, Marci Lee Nilsen, Marion A. Hughes, Moon Fenton, Mark Kubik, Shaum Sridharan, David A. Clump, Heath D. Skinner, Jonas T. Johnson, Simion I. Chiosea, James Ohr, Umamaheswar Duvvuri, Seungwon Kim, Katie S. Traylor, Robert Ferris, Dan P. Zandberg
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 7, Iss 3, Pp 757-765 (2022)
Abstract Objectives Data on the efficacy of including definitive local therapy to the primary site for head and neck squamous cell carcinoma (HNSCC) patients with synchronous distant metastasis are lacking. In multiple different solid tumor types, th
Externí odkaz:
https://doaj.org/article/8e063f3a91944f3ebecff1d2f616b066
Autor:
Thomas M. Kaffenberger, Ankur K. Patel, Lingyun Lyu, Jinhong Li, Tamara Wasserman‐Wincko, Dan P. Zandberg, David A. Clump, Jonas T. Johnson, Marci L. Nilsen
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 6, Iss 5, Pp 983-990 (2021)
Abstract Objectives Oropharyngeal squamous cell carcinoma (OPSCC) treatment results in impaired swallowing and quality of life (QOL). We analyzed a cross‐section of advanced stage OPSCC patients treated with multimodal therapies at our Survivorship
Externí odkaz:
https://doaj.org/article/7d3e4479f0ba4dedb79d3aa3c608108c
Autor:
Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/195a4377dadb4e879675192629df7c9e
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Head and neck cancer is the 6th most common cancer worldwide with the most common histology being squamous cell carcinoma (HNSCC). While the majority of patients present at a stage where curative intent therapy is possible, when patients recur and/or
Externí odkaz:
https://doaj.org/article/62d892eae3b1422ebff70c5535d36f0d
Autor:
Greg M Delgoffe, Kristin DePeaux, Angen Liu, Dan P Zandberg, Ashley V Menk, Maria Velez, Daniel Normolle
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
The majority of patients with recurrent/metastatic squamous cell carcinoma of the head and neck (HNSCC) (R/M) do not benefit from anti-PD-1 therapy. Hypoxia induced immunosuppression may be a barrier to immunotherapy. Therefore, we examined the metab
Externí odkaz:
https://doaj.org/article/d0916971c66149a6a4ea79c16d0bb5d0